Safety of Pharmacotherapy in COVID-19 Patients: A Literature Review

Safety of Pharmacotherapy in COVID-19 Patients: A Literature Review

The safety of COVID-19 pharmacotherapy is a relevant issue, first of all, because of the current lack of experience with using particular medicinal products and with off-label prescribing. The aim of the study was to analyse information on potential adverse drug reactions (ADRs) and their predictors...

Full description

Bibliographic Details
Main Authors: A. V. Kryukov, A. S. Zhiryakova, Yu. V. Shevchuk, A. V. Matveev, V. I. Vechorko, O. V. Averkov, S. V. Glagolev, I. I. Temirbulatov, K. B. Mirzaev, N. P. Denisenko, Sh. P. Abdullaev, D. A. Sychev
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2022-12-01
Series:Безопасность и риск фармакотерапии
Subjects:
covid-19
adverse drug reactions
pharmacovigilance
drug-drug interactions
pharmacogenetics
nirmatrelvir+ritonavir
interleukin inhibitors
monoclonal antibodies
Online Access:https://www.risksafety.ru/jour/article/view/340

Internet

https://www.risksafety.ru/jour/article/view/340

Similar Items